Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00828633 · ClinicalTrials.gov registry record
Health-Related Quality of Life in Gay Men With Localized Prostate Cancer
A clinical trial, sponsored by Baylor College of Medicine.
- Completed
- Registry status
- 92
- Enrollment target
NCT00828633: Completed study, sponsored by Baylor College of Medicine.
NCT00828633 is a clinical trial that has completed, run by Baylor College of Medicine. The registered enrollment target is 92 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00828633 has completed, sponsored by Baylor College of Medicine.
- COMPLETED
- Registry status
- 92 participants
- Enrollment target
Study Summary
RATIONALE: Gathering information about prostate cancer, treatment, and quality of life from gay men with prostate cancer may help doctors plan the best treatment. PURPOSE: This clinical trial is collecting information about health-related quality of life from gay men with localized prostate cancer.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 92 participants |
| Start Date | 2008-08 |
| Est. Completion | 2015-06 |
What the finished NCT00828633 record still lists
NCT00828633 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 92 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00828633 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00828633 about?
NCT00828633 is a clinical study titled "Health-Related Quality of Life in Gay Men With Localized Prostate Cancer". RATIONALE: Gathering information about prostate cancer, treatment, and quality of life from gay men with prostate cancer may help doctors plan the best treatment. PURPOSE: This clinical trial is collecting information about health-related quality of life from gay men with localized prostate cancer.
What is the current status of trial NCT00828633?
This trial is currently completed. The enrollment target is 92 participants. The study started on 2008-08. Estimated completion is 2015-06.
Who is sponsoring clinical trial NCT00828633?
This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03184545 · 92 participants · Phase 3
Comparing the Outcome of Electrical Stimulation and Physical Therapy in Patellofemoral Pain Syndrome
- NCT04172532 · 92 participants · Phase 1
Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer
- NCT04508088 · 92 participants
Skeletal Health and Bone Marrow Composition in Newly Diagnosed Adolescents With Crohn Disease
- NCT04840602 · 92 participants · Phase 2
Testing the Combination of Venetoclax and Rituximab, in Comparison to the Usual Treatment (Ibrutinib Plus Rituximab or Zanubrutinib Alone) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia